Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sands

Showing results (191-200 of 513) with videos related to

Pageof 52
Sort By:
Scientific Reports|February 3, 2024
Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable deviceRobert P Hirten, Kai-Chun Lin, Jessica Whang, et al.
Inflammatory Bowel Diseases|December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist TherapyBruce E Sands, William J Sandborn, Gert Van Assche, et al.
Inflammatory Bowel Diseases|February 22, 2017
Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database StudyPriti Poojary, Aparna Saha, Kinsuk Chauhan, et al.
Journal of Clinical Gastroenterology|July 11, 2006
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn diseaseBruce E Sands, William J Sandborn, Douglas C Wolf, et al.
Surgery|May 4, 2010
Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease?Liliana Bordeianou, Sharon L Stein, Vanessa P Ho, et al.
Inflammatory Bowel Diseases|October 23, 2019
Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict RecurrenceRobert P Hirten, Ryan C Ungaro, Daniel Castaneda, et al.
Inflammatory Bowel Diseases|November 24, 2015
Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative ColitisBruce E Sands, Shashidhar Joshi, Jonathan Haddad, et al.
American Journal of Obstetrics and Gynecology|August 1, 1995
Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birthP J Meis, R Michielutte, T J Peters, et al.
Paediatric and Perinatal Epidemiology|July 1, 1997
Factors associated with term low birthweight in Cardiff, WalesP J Meis, R Michielutte, T J Peters, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2020
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Daniel Quirk, et al.
Pageof 52

Showing results (191-200 of 513) with videos related to

Sort By:
Pageof 52
Scientific Reports|February 3, 2024
Longitudinal assessment of sweat-based TNF-alpha in inflammatory bowel disease using a wearable deviceRobert P Hirten, Kai-Chun Lin, Jessica Whang, et al.
Inflammatory Bowel Diseases|December 9, 2016
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease in Patients Naïve to or Who Have Failed Tumor Necrosis Factor Antagonist TherapyBruce E Sands, William J Sandborn, Gert Van Assche, et al.
Inflammatory Bowel Diseases|February 22, 2017
Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database StudyPriti Poojary, Aparna Saha, Kinsuk Chauhan, et al.
Journal of Clinical Gastroenterology|July 11, 2006
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn diseaseBruce E Sands, William J Sandborn, Douglas C Wolf, et al.
Surgery|May 4, 2010
Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease?Liliana Bordeianou, Sharon L Stein, Vanessa P Ho, et al.
Inflammatory Bowel Diseases|October 23, 2019
Anastomotic Ulcers After Ileocolic Resection for Crohn's Disease Are Common and Predict RecurrenceRobert P Hirten, Ryan C Ungaro, Daniel Castaneda, et al.
Inflammatory Bowel Diseases|November 24, 2015
Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative ColitisBruce E Sands, Shashidhar Joshi, Jonathan Haddad, et al.
American Journal of Obstetrics and Gynecology|August 1, 1995
Factors associated with preterm birth in Cardiff, Wales. II. Indicated and spontaneous preterm birthP J Meis, R Michielutte, T J Peters, et al.
Paediatric and Perinatal Epidemiology|July 1, 1997
Factors associated with term low birthweight in Cardiff, WalesP J Meis, R Michielutte, T J Peters, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 31, 2020
Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Daniel Quirk, et al.
Pageof 52